Advertisement

Metastatic breast cancer treated with lapatinib with a prolonged benefit: a case report and a review of therapeutic options available

Abstract

A 53-year-old woman was treated, after trastuzumab progression of HER2-positive metastatic disease, with capecitabine plus lapatinib and subsequently with lapatinib alone. To date, she has had persistent remission of disease since 2009.

Tumori 2013; 99(6): e269 - e272

Article Type: CASE REPORT

DOI:10.1700/1390.15466

Authors

Giulia Valeria Bianchi, Matteo Duca, Lorenzo Sica, Gabriella Mariani

Article History

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Bianchi, Giulia Valeria [PubMed] [Google Scholar]
    Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
  • Duca, Matteo [PubMed] [Google Scholar]
    Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
  • Sica, Lorenzo [PubMed] [Google Scholar]
    Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
  • Mariani, Gabriella [PubMed] [Google Scholar]
    Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.